Your browser is no longer supported. Please, upgrade your browser.
HRTX Heron Therapeutics, Inc. daily Stock Chart
HRTX [NASD]
Heron Therapeutics, Inc.
Index- P/E- EPS (ttm)-2.49 Insider Own0.10% Shs Outstand90.55M Perf Week-1.24%
Market Cap2.30B Forward P/E- EPS next Y-1.81 Insider Trans302.60% Shs Float89.93M Perf Month26.34%
Income-196.40M PEG- EPS next Q-0.62 Inst Own- Short Float20.53% Perf Quarter21.11%
Sales139.70M P/S16.48 EPS this Y33.10% Inst Trans-0.77% Short Ratio16.76 Perf Half Y39.21%
Book/sh3.57 P/B7.12 EPS next Y26.70% ROA-46.10% Target Price40.90 Perf Year-2.46%
Cash/sh2.83 P/C8.98 EPS next 5Y- ROE-60.80% 52W Range15.68 - 28.70 Perf YTD-2.00%
Dividend- P/FCF- EPS past 5Y6.50% ROI-49.10% 52W High-11.43% Beta1.56
Dividend %- Quick Ratio3.50 Sales past 5Y- Gross Margin59.00% 52W Low62.12% ATR0.88
Employees198 Current Ratio3.80 Sales Q/Q115.20% Oper. Margin- RSI (14)65.80 Volatility2.72% 3.83%
OptionableYes Debt/Eq0.02 EPS Q/Q14.70% Profit Margin- Rel Volume0.84 Prev Close25.56
ShortableYes LT Debt/Eq0.00 EarningsNov 13 Payout- Avg Volume1.10M Price25.42
Recom1.60 SMA202.63% SMA5017.44% SMA20024.63% Volume920,619 Change-0.55%
Jan-16-19Reiterated Needham Buy $66 → $64
Apr-05-18Initiated Evercore ISI Outperform $56
Mar-19-18Reiterated Mizuho Buy $28 → $35
Mar-01-18Reiterated Needham Buy $28 → $30
Jan-03-18Initiated Leerink Partners Outperform $22
Sep-27-17Initiated Northland Capital Outperform $40
Feb-27-17Initiated Needham Buy $28
Oct-26-16Initiated Aegis Capital Buy
Sep-06-16Resumed Lake Street Buy $45
May-03-16Initiated Cantor Fitzgerald Buy
Dec-10-15Initiated Lake Street Buy $45
Sep-23-15Reiterated Leerink Partners Outperform $38 → $57
Sep-02-15Initiated BofA/Merrill Buy $46
Aug-03-15Reiterated Brean Capital Buy $40 → $45
Jun-30-15Reiterated JMP Securities Mkt Outperform $25 → $33
Jun-19-15Reiterated Leerink Partners Outperform $26 → $38
Aug-07-14Initiated Noble Financial Buy $18
Dec-12-19 01:44PM  Hedge Funds Cashed Out Of Heron Therapeutics Inc (HRTX) Too Early Insider Monkey
Dec-10-19 05:18AM  Moving Average Crossover Alert: Heron Therapeutics Zacks
Dec-06-19 08:00AM  12 Biotech Stocks Primed For A Short Squeeze Benzinga
Dec-03-19 07:30AM  Health Canada Grants Priority Review Status for Heron Therapeutics' New Drug Submission for HTX-011 for Management of Postoperative Pain PR Newswire
Nov-26-19 04:05PM  Heron Therapeutics to Present at the Evercore ISI HealthCONx Conference PR Newswire
Nov-25-19 09:13AM  Heron Therapeutics, Inc. (HRTX) Shares March Higher, Can It Continue? Zacks
Nov-22-19 03:22PM  3 Strong Buy Biotech Stocks to Watch After Stifel Healthcare Conference TipRanks
Nov-15-19 09:00AM  Heron Therapeutics (HRTX) Upgraded to Buy: Here's Why Zacks
08:24AM  Heron Therapeutics, Inc. Third-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For Next Year Simply Wall St.
Nov-14-19 04:05PM  Heron Therapeutics to Present at the Jefferies London Healthcare Conference PR Newswire
Nov-13-19 04:05PM  Heron Therapeutics to Present at the Stifel 2019 Healthcare Conference PR Newswire
Nov-12-19 09:45AM  Heron Therapeutics (HRTX) Reports Q3 Loss, Tops Revenue Estimates Zacks
08:30AM  Heron Therapeutics Announces Financial Results for the Three and Nine Months Ended September 30, 2019 and Highlights Recent Corporate Updates PR Newswire
Nov-11-19 01:59PM  Is Heron Therapeutics, Inc.'s (NASDAQ:HRTX) CEO Pay Fair? Simply Wall St.
Oct-30-19 10:33AM  Heron Therapeutics (HRTX) Expected to Beat Earnings Estimates: Should You Buy? Zacks
05:15AM  2 Small Biotech Stocks Spurt Ahead on Positive Developments TheStreet.com
Oct-28-19 09:08AM  Is Heron Therapeutics Inc (HRTX) Going to Burn These Hedge Funds? Insider Monkey +5.86%
08:30AM  Heron Therapeutics Announces FDA Acceptance of New Drug Application Resubmission for HTX-011 for Management of Postoperative Pain PR Newswire
Oct-22-19 08:30AM  Heron Announces FDA Approval of Supplemental New Drug Application to Expand CINVANTI® Label for Single-Dose Regimen for Patients Receiving Moderately Emetogenic Chemotherapy (MEC) PR Newswire
Oct-07-19 12:14PM  Weekly CEO Buys Highlight GuruFocus.com
Oct-04-19 10:00PM  Bragar Eagel & Squire is Investigating Certain Officers and Directors of Healthcare Services Group, Heron Therapeutics, Immunomedics, and Karyopharm and Encourages Investors to Contact the Firm GlobeNewswire -10.04%
06:10AM  How Heron Therapeutics, Inc. (NASDAQ:HRTX) Can Impact Your Portfolio Volatility Simply Wall St.
Oct-03-19 10:37PM  Heron Therapeutics Announces Pricing of Public Offering of Common Stock PR Newswire
04:01PM  Heron Therapeutics Announces Proposed Public Offering of Common Stock PR Newswire
09:42AM  Heron Therapeutics (HRTX) Catches Eye: Stock Jumps 6.2% Zacks
Oct-02-19 12:23PM  Heron Shares Rise on Phase III Results of Agent Used in Knee Replacements TheStreet.com +6.15%
07:45AM  Heron Announces Positive Topline Results from Phase 3b Clinical Study of HTX-011 in Total Knee Arthroplasty PR Newswire
Oct-01-19 04:10PM  Heron Therapeutics Appoints Kimberly Manhard to Board of Directors PR Newswire -5.08%
04:05PM  Heron Therapeutics Appoints Stephen Davis to Board of Directors PR Newswire
08:30AM  Heron Therapeutics Resubmits New Drug Application to FDA for HTX-011 for the Management of Postoperative Pain PR Newswire
Sep-25-19 04:05PM  Heron Therapeutics to Present at the 2019 Cantor Global Healthcare Conference PR Newswire
Sep-04-19 10:00AM  How Many Heron Therapeutics, Inc. (NASDAQ:HRTX) Shares Did Insiders Buy, In The Last Year? Simply Wall St.
Aug-30-19 06:14PM  5 Health Care Stocks in Gurus' Portfolios GuruFocus.com
Aug-29-19 07:31AM  The Smartest People on Wall Street Are Buying These 3 Stocks -- Should You? Motley Fool +6.47%
Aug-20-19 08:30AM  Heron Therapeutics Announces Publication of Results from EPOCH 2, a Phase 3 Study of HTX-011 in Patients Undergoing Hernia Repair Surgery PR Newswire
Aug-06-19 03:40PM  Biotech Stocks to Watch Through the 2nd Half of 2019 GuruFocus.com
Aug-05-19 03:30PM  FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of HRTX, EGBN and CARB ACCESSWIRE
03:00PM  Final Deadline:(HRTX) Heron Therapeutics, Inc. - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action and Lead Plaintiff Deadline: August 5, 2019 PR Newswire
02:18PM  Is Heron Therapeutics (NASDAQ:HRTX) Using Debt Sensibly? Simply Wall St.
10:45AM  SHAREHOLDER ALERT: HRTX RBGLY JE: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines ACCESSWIRE
10:30AM  Final Deadline:(HRTX) Heron Therapeutics, Inc. - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action and Lead Plaintiff Deadline: August 5, 2019 ACCESSWIRE
09:45AM  Heron Therapeutics (HRTX) Reports Q2 Loss, Tops Revenue Estimates Zacks
08:30AM  Heron Therapeutics Announces Financial Results for the Three and Six Months Ended June 30, 2019 and Highlights Recent Corporate Updates PR Newswire
08:15AM  MONDAY DEADLINE ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Heron Therapeutics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm GlobeNewswire
Aug-02-19 03:30PM  CLASS ACTION UPDATE for HRTX, EROS and MNK: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders ACCESSWIRE
03:00PM  Final Deadline: (HRTX) Heron Therapeutics, Inc. - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action and Lead Plaintiff Deadline: August 5, 2019 GlobeNewswire
09:43AM  The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of HRTX, STG, PVTL and GTT GlobeNewswire
07:10AM  Pawar Law Group Reminds Investors of August 5 Deadline in Securities Class Action Lawsuit Against Heron Therapeutics, Inc. HRTX GlobeNewswire
Aug-01-19 04:00PM  The Gross Law Firm Announces Class Actions on Behalf of Shareholders of HRTX, RLGY and NFLX ACCESSWIRE
02:46PM  LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Heron Therapeutics, Inc. To Contact The Firm GlobeNewswire
Jul-31-19 02:00PM  The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of HRTX, PVTL and INS ACCESSWIRE
12:53PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Heron Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline HRTX GlobeNewswire
11:15AM  The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of HRTX, PVTL and RBGLY ACCESSWIRE
10:29AM  Approaching Deadline: (HRTX) Heron Therapeutics, Inc. - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action and Lead Plaintiff Deadline: August 5, 2019 ACCESSWIRE
Jul-30-19 07:05PM  The Gross Law Firm Announces Class Actions on Behalf of Shareholders of HRTX, NFLX and LB ACCESSWIRE
06:30PM  Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Heron Therapeutics, Box, Beazer Homes, and Cloudera and Encourages Investors to Contact the Firm GlobeNewswire
11:20AM  CLASS ACTION UPDATE for MMM, HRTX, CTST and NGHC: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire
10:47AM  HRTX CLASS ACTION DEADLINE: Bernstein Liebhard LLP Reminds Investors That Approximately 6 Days Remain To Make A Motion For Lead Plaintiff In A Securities Class Action Lawsuit Against Heron Therapeutics, INC. HRTX GlobeNewswire
Jul-29-19 03:00PM  3 Top Biotech Stocks to Buy Right Now Motley Fool
02:15PM  CLASS ACTION UPDATE for HRTX, STG and RLGY: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders ACCESSWIRE
01:32PM  ROSEN, A TOP RANKED LAW FIRM, Reminds Heron Therapeutics, Inc. Investors of Important August 5th Deadline in the Securities Class Action; Encourages Investors with Losses in Excess of $100K to Contact the Firm HRTX GlobeNewswire
10:45AM  CLASS ACTION UPDATE for CYH, HRTX and EROS: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders ACCESSWIRE
10:28AM  Upcoming Deadline: (HRTX) Heron Therapeutics, Inc. - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action and Lead Plaintiff Deadline: August 5, 2019 ACCESSWIRE
09:10AM  7-DAY DEADLINE ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Heron Therapeutics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm GlobeNewswire
Jul-26-19 04:15PM  SHAREHOLDER ALERT: HRTX EQT FRED: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines ACCESSWIRE
03:00PM  Heron Therapeutics, Inc. (HRTX), Beazer Homes USA, Inc. (BZH) & Ascena Retail Group, Inc. (ASNA) - Bronstein, Gewirtz & Grossman, LLC Class Action Update GlobeNewswire
01:20PM  The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of HRTX, ASNA and FRED ACCESSWIRE
11:00AM  LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Heron Therapeutics, Inc. To Contact The Firm ACCESSWIRE
09:54AM  CLASS ACTION UPDATE for HRTX, FDX and EQT: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders ACCESSWIRE
09:21AM  Zhang Investor Law Reminds Investors of August 5 Deadline in Securities Class Action Lawsuit Against Heron Therapeutics, Inc. HRTX GlobeNewswire
Jul-25-19 10:45AM  The Gross Law Firm Announces Class Actions on Behalf of Shareholders of HRTX, DBD and RLGY ACCESSWIRE
10:21AM  HRTX CLASS ACTION DEADLINE: Bernstein Liebhard LLP Reminds Investors That Approximately 11 Days Remain to Make a Motion for Lead Plaintiff in a Securities Class Action Lawsuit Against Heron Therapeutics, Inc. HRTX GlobeNewswire
Jul-24-19 11:00AM  SHAREHOLDER ALERT: HRTX PVTL OMCL: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines ACCESSWIRE
10:01AM  Heron Therapeutics, Inc. (HRTX), Beazer Homes USA, Inc. (BZH) & Ascena Retail Group, Inc. (ASNA) - Bronstein, Gewirtz & Grossman, LLC Class Action Update ACCESSWIRE
Jul-23-19 09:50PM  The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of CYH, HRTX and PVTL ACCESSWIRE
09:30PM  Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against A.O. Smith Corporation, Community Health Systems, Metro Bank, and Heron Therapeutics and Encourages Investors to Contact the Firm GlobeNewswire
06:21PM  Federman & Sherwood Reminds Investors of Imminent Lead Plaintiff Deadline in Securities Class Action Lawsuit Against Heron Therapeutics, Inc. Business Wire
05:35PM  The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of HRTX, PVTL and FRED ACCESSWIRE
05:00PM  LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Heron Therapeutics, Inc. To Contact The Firm GlobeNewswire
Jul-22-19 07:05PM  The Gross Law Firm Announces Class Actions on Behalf of Shareholders of MBNKF, HRTX and CLDR ACCESSWIRE
05:16PM  Pawar Law Group Reminds Investors of August 5 Deadline in Securities Class Action Lawsuit Against Heron Therapeutics, Inc. HRTX GlobeNewswire
04:10PM  FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of HRTX, CLDR and PYX ACCESSWIRE
02:15PM  LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Heron Therapeutics, Inc. To Contact The Firm ACCESSWIRE
11:00AM  CLASS ACTION UPDATE for LTHM, HRTX and BOX: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders ACCESSWIRE
10:10AM  UPCOMING DEADLINE ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Heron Therapeutics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm GlobeNewswire
10:01AM  Heron Therapeutics, Inc. (HRTX), Beazer Homes USA, Inc. (BZH) & Ascena Retail Group, Inc. (ASNA) - Bronstein, Gewirtz & Grossman, LLC Class Action Reminder ACCESSWIRE
Jul-21-19 11:10AM  FILING DEADLINE - Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of LTHM, HRTX and ASNA ACCESSWIRE
Jul-20-19 12:00PM  ROSEN, A TOP RANKED LAW FIRM, Reminds Heron Therapeutics, Inc. Investors of Important August 5th Deadline in the Securities Class Action HRTX GlobeNewswire
Jul-19-19 06:15PM  SHAREHOLDER ALERT: BE HRTX DBD: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines ACCESSWIRE
04:00PM  LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Heron Therapeutics, Inc. To Contact The Firm ACCESSWIRE
03:25PM  CLASS ACTION UPDATE for HRTX, CLDR and BUD: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders ACCESSWIRE
03:00PM  Metro Bank PLC (MBNKF), Heron Therapeutics, Inc. (HRTX) & Beazer Homes USA, Inc. (BZH) - Bronstein, Gewirtz & Grossman, LLC Class Action Update GlobeNewswire
11:25AM  SHAREHOLDER ALERT: HL HRTX CLDR: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines ACCESSWIRE
10:52AM  Metro Bank PLC (MBNKF), Heron Therapeutics, Inc. (HRTX) & Beazer Homes USA, Inc. (BZH) - Bronstein, Gewirtz & Grossman, LLC Class Action ACCESSWIRE
Jul-18-19 02:20PM  CLASS ACTION UPDATE for LTHM, HRTX and RMED: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders ACCESSWIRE
02:05PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Heron Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline - HRTX ACCESSWIRE
01:50PM  LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Heron Therapeutics, Inc. To Contact The Firm ACCESSWIRE
Jul-17-19 06:00PM  The Gross Law Firm Announces Class Actions on Behalf of Shareholders of HRTX, EROS and RBGLY ACCESSWIRE
05:25PM  INVESTOR ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Heron Therapeutics, Inc. and Encourages Investors with Losses to Contact the Firm ACCESSWIRE
12:10PM  FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of HRTX, PVTL and ZUO ACCESSWIRE
Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet medical needs. The company's product candidates utilize its proprietary Biochronomer drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single administration. It offers SUSTOL (granisetron) extended-release injection for the prevention of acute and delayed nausea and vomiting associated with moderately emetogenic chemotherapy, or anthracycline and cyclophosphamide combination chemotherapy regimens. The company is also developing CINVANTI, an intravenous formulation of aprepitant, a substance P/neurokinin-1 receptor antagonist for the prevention of acute and delayed nausea and vomiting associated with highly emetogenic cancer chemotherapy, as well as nausea and vomiting associated with moderately emetogenic cancer chemotherapy; and HTX-011, an investigational, long-acting, and extended-release formulation of the local anesthetic bupivacaine in a fixed-dose combination with the anti-inflammatory meloxicam for post-operative pain management. The company was formerly known as A.P. Pharma, Inc. and changed its name to Heron Therapeutics, Inc. in January 2014. Heron Therapeutics, Inc. was founded in 1983 and is headquartered in San Diego, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
MANHARD KIMBERLYExecutive VP, Drug DevelopmentNov 29Option Exercise13.0024,000312,00024,000Dec 03 06:30 PM
MANHARD KIMBERLYExecutive VP, Drug DevelopmentNov 29Sale26.0024,000624,0000Dec 03 06:30 PM
TANG KEVIN CDirectorOct 04Buy17.50285,7144,999,9955,799,810Oct 07 05:18 PM
Quart Barry DChief Executive OfficerOct 03Buy17.504,57179,99394,652Oct 04 07:58 PM
POYHONEN JOHNEVP, Chief Commercial OfficerOct 03Buy17.505,14390,00318,143Oct 04 07:56 PM
POYHONEN JOHNDirectorMay 22Buy17.553,00052,65013,000May 23 08:39 AM
Christian WaageDirectorMay 15Buy18.041,40025,2621,400May 16 08:44 AM
MANHARD KIMBERLYExecutive VP, Drug DevelopmentMay 01Sale18.861,10920,9180May 02 08:40 PM